Showing results (61-70 of 655) with videos related to
Sort By:
Pageof 66
Journal of Clinical Pharmacology|June 29, 2021
Dose-Related Adverse Drug Events in Neonates: Recognition and AssessmentKarel Allegaert, John van den AnkerPharmaceutics|January 26, 2024
Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on "De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling"Karel Allegaert, Anne Smits, Pieter AnnaertEuropean Journal of Pediatrics|February 18, 2005
A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosusRonald L Thomas, Graham C Parker, Bart Van Overmeire, et al.Biopharmaceutics & Drug Disposition|August 18, 2021
Physiologically based pharmacokinetic modelling of acetaminophen in preterm neonates-The impact of metabolising enzyme ontogeny and reduced cardiac outputOlusola Olafuyi, Mohammad Yaseen Abbasi, Karel AllegaertCurrent Pharmaceutical Design|March 6, 2012
Pharmacokinetics of Aminoglycosides in the NewbornJohannes N van den Anker, Karel AllegaertNeonatology|June 17, 2014
Clinical pharmacology in neonates: small size, huge variabilityKarel Allegaert, John N van den AnkerSeminars in Fetal & Neonatal Medicine|April 8, 2022
From immature pharmacotherapy towards pharmacotherapy of the immatureKarel Allegaert, John N van den AnkerSeminars in Fetal & Neonatal Medicine|July 20, 2017
Perinatal and neonatal use of paracetamol for pain reliefKarel Allegaert, John N van den AnkerBritish Journal of Clinical Pharmacology|October 9, 2024
Evaluation of the effect of CYP2D6 and OCT1 polymorphisms on the pharmacokinetics of tramadol: Implications for clinical safety and dose rationale in paediatric chronic painPaul Healy, Karel Allegaert, Oscar Della PasquaCurrent Pharmaceutical Design|May 9, 2012
Pharmacokinetics of aminoglycosides in the newbornJohannes N van den Anker, Karel AllegaertPageof 66